High resolution carotid black-blood 3T MR with parallel imaging and dedicated 4-channel surface coils

14 healthy volunteers and 14 patients with intimal thickening as proven by duplex ultrasound had their carotid arteries imaged at 3 T using a multi-sequence protocol (time-of-flight MR angiography, pre-contrast T1w-, PDw- and T2w sequences in the volunteers, additional post-contrast T1w- and dynamic contrast enhanced sequences in patients). To assess intrascan reproducibility, 10 volunteers were scanned twice within 2 weeks.Intrascan reproducibility for quantitative measurements of lumen, wall and outer wall areas was excellent with Intraclass Correlation Coefficients >0.98 and measurement errors of 1.5%, 4.5% and 1.9%, respectively. Patients had larger wall areas than volunteers in both common carotid and internal carotid arteries and smaller lumen areas in internal carotid arteries (p < 0.001). Positive correlations were found between wall area and cardiovascular risk factors such as age, hypertension, coronary heart disease and hypercholesterolemia (Spearman's r = 0.45-0.76, p < 0.05). No significant correlations were found between wall area and body mass index, gender, diabetes or a family history of cardiovascular disease.The findings of this study indicate that high resolution carotid black-blood 3 T MR with parallel imaging is a fast, reproducible and robust method to assess carotid atherosclerotic plaque in vivo and this method is ready to be used in clinical practice.Complications of cardiovascular disease, including stroke, myocardial infarction, and sudden cardiac death, are the most common causes of death in the western world. The challenge for screening and diagnostic methods is to identify patients at high risk who have lesions that are vulnerable to thrombosis, so-called "vulnerable plaques", before the event occurs. Imaging methods have the potential to not only be used as a screening tool for the presence of atherosclerosis but also to help distinguish stable from vulnerable plaques and finally to distinguish between patients with low risk from thos